Gadolinium
- Generic Name
- Gadolinium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- Gd
- CAS Number
- 7440-54-2
- Unique Ingredient Identifier
- AU0V1LM3JT
- Background
Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Cardiac (CMRI) Assessment of Acromegaly
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 28
- Registration Number
- NCT02948322
- Locations
- 🇫🇷
AP-HP, Bicêtre Hospital, Le Kremlin Bicêtre, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath